MENU
+Compare
KRYS
Stock ticker: NASDAQ
AS OF
Jun 4, 01:43 PM (EDT)
Price
$133.20
Change
+$2.29 (+1.75%)
Capitalization
3.78B

KRYS Krystal Biotech Forecast, Technical & Fundamental Analysis

Krystal Biotech Inc is engaged in the healthcare sector in the United States... Show more

KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for KRYS with price predictions
Jun 03, 2025

KRYS's RSI Oscillator ascends from oversold territory

The RSI Indicator for KRYS moved out of oversold territory on May 29, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In of the 17 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where KRYS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KRYS just turned positive on May 29, 2025. Looking at past instances where KRYS's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KRYS advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

KRYS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on KRYS as a result. In of 109 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRYS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KRYS entered a downward trend on June 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.842) is normal, around the industry mean (16.383). P/E Ratio (31.393) is within average values for comparable stocks, (59.545). KRYS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.229). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (11.737) is also within normal values, averaging (264.152).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KRYS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

KRYS is expected to report earnings to rise 27.50% to $1.53 per share on August 11

Krystal Biotech KRYS Stock Earnings Reports
Q2'25
Est.
$1.53
Q1'25
Missed
by $0.26
Q4'24
Beat
by $0.31
Q3'24
Missed
by $0.08
Q2'24
Missed
by $0.25
The last earnings report on May 06 showed earnings per share of $1.20, missing the estimate of $1.46. With 13.91K shares outstanding, the current market capitalization sits at 3.78B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company which provides therapies for rare and orphan diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2100 Wharton Street
Phone
+1 412 586-5830
Employees
229
Web
https://www.krystalbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GFFFX77.530.32
+0.41%
American Funds Growth Fund of Amer F2
SUWIX34.05N/A
N/A
DWS Core Equity Inst
CFIGX13.78N/A
N/A
Columbia Flexible Capital Income C
LFGAX37.08N/A
N/A
Lord Abbett Focused Growth A
MMOGX17.34N/A
N/A
MassMutual Small Cap Opps Y

KRYS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with ACLX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+4.43%
ACLX - KRYS
57%
Loosely correlated
+5.18%
IDYA - KRYS
56%
Loosely correlated
+1.98%
CGON - KRYS
54%
Loosely correlated
+0.75%
CRNX - KRYS
54%
Loosely correlated
+0.69%
XNCR - KRYS
53%
Loosely correlated
+6.53%
More